|
Program Goals
In order to provide the most up-to-date treatment and care to patients with cancer, information regarding new agents must be spread throughout the healthcare professional community. The Practical Applications of New Agents in Oncology conference disseminates this information to the healthcare professional who, in turn, will use this information to provide the highest quality cancer treatment.
This conference will focus on the large number of new anticancer agents and related supportive therapeutics that have been approved over the last several years, as well as those that will likely be approved. Speakers will discuss the incorporation of these agents into standard clinical practice, providing guidance to front-line clinicians regarding current or projected appropriate use of these therapeutics. Topics will include both early and late stages of various malignancies, and combined modality therapies (chemotherapy + surgery + radiotherapy) whenever pertinent.
Target Audience
There is a necessity to continually update the community of medical professionals within the field of oncology with new agents and their uses in the clinical setting. A need also exits to foster collaboration between physicians, pharmacists and nurses treating cancer patients. This conference offers an opportunity to gather these professionals to one arena to learn about and discuss new agents in oncology and their uses in the clinical setting.
The conference has an attractive format and represents national points of view, making it a stimulating meeting for physicians, pharmacists and nurses.
Objectives
As a result of attending the conference, attendees will be able to:
- Cite the results of clinical studies of new anticancer agents and current dilemmas with a principal focus on discerning the role or eventual role of new therapies in the clinical practice of oncology.
- Describe the procedure for determining incorporation of new anticancer agents and therapeutics into clinical practice.
Educational Methods
The course will include lectures and opportunity for questions and answers.
Accreditation
Continuing Medical Education Statements
The UT Health Science Center San Antonio School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UT Health Science Center San Antonio School of Medicine designates this educational activity for a maximum of 8.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education Statements
The University of Texas Health Science Center at San Antonio, School of Nursing, is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity meets Type I criteria for mandatory continuing education requirements toward relicensure as established by the Texas Board of Nursing. This education program offers up to 9.9 nursing contact hours.
Conference Contact
Rich Markow, Symposia Director
UT Health Science Center San Antonio
Continuing Medical Education
Scientific Symposia Group
7703 Floyd Curl Drive, MC8224
San Antonio, TX 78229-3900
Tel (210) 567-6070
Fax (210) 567-6072
E-mail markow@uthscsa.edu
Conference Administration
All administrative functions of this conference occur in the Scientific Symposia operations office at the address above.
Program Committee
Andrew Brenner, MD, PhD
Assistant Professor, Hematology and Medical Oncology
Cancer Therapy & Research Center at UT Health Science Center San Antonio
Jennifer Carew, PhD
Assistant Professor, Hematology and Medical Oncology
Cancer Therapy & Research Center at UT Health Science Center San Antonio
Tyler Curiel, MD, MPH
Course Co-Director
Executive Director,
Cancer Therapy & Research Center at UT Health Science Center San Antonio
Francis Giles, MB, MD, FRCPI, FRCPath
Course Co-Director
Deputy Director,
Cancer Therapy & Research Center at UT Health Science Center San Antonio
Institute for Drug Development
Brenda Johnson MEd
Director, Continuing Medical Education at UT Health Science Center San Antonio
Anand Karnad, MD
Professor, Hematology and Medical Oncology, Castella Aging Chair
Cancer Therapy & Research Center at UT Health Science Center San Antonio
Gerardo Medina, RN, OCN, CCRP
Research Nursing Supervisor
Cancer Therapy & Research Center at UT Health Science Center San Antonio
Institute for Drug Development
Monica Mita, MD
Assistant Professor, Hematology and Medical Oncology
Cancer Therapy & Research Center at UT Health Science Center San Antonio
Institute for Drug Development
Rosalie Tierney-Gumaer, BSN, MSN, MOH, CPHQ
Director, Continuing Nursing Education, at UT Health Science Center San Antonio
Gail Tomlinson, MD, PhD
Professor, Pediatrics
Greehey Distinguished Chair in Genetics of Cancer
|
Home
Practical Applications of New Agents in Oncology
